In this article, we provide an overview of the Janus kinase–signal transducer and activator of transcription 3 (JAK–STAT3) pathway involved in ischemia/reperfusion injury in the myocardium, which may be activated by the vasospasm-inducing action of the drug. The gene discussed is STAT3; the disease is ischemia.